These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3092623)
1. Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials. Morganroth J Am J Cardiol; 1986 Aug; 58(5):74C-82C. PubMed ID: 3092623 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781 [TBL] [Abstract][Full Text] [Related]
3. Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias. Morganroth J; Pool P; Miller R; Hsu PH; Lee I; Clark DM Am J Cardiol; 1986 Apr; 57(10):769-74. PubMed ID: 3083665 [TBL] [Abstract][Full Text] [Related]
4. Dosing recommendations for encainide. Antonaccio MJ; Verjee S Am J Cardiol; 1986 Aug; 58(5):114C-116C. PubMed ID: 3092615 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study. Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017 [TBL] [Abstract][Full Text] [Related]
6. Comparison of encainide and quinidine for supraventricular tachyarrhythmias. Mäkynen PJ; Koskinen PJ; Saaristo TE; Liisanantti RK Am J Cardiol; 1988 Dec; 62(19):55L-59L. PubMed ID: 3144169 [TBL] [Abstract][Full Text] [Related]
7. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias. Hohnloser SH; Zabel M; Zehender M; Meinertz T; Just H Am J Cardiol; 1989 Jan; 63(1):73-6. PubMed ID: 2462343 [TBL] [Abstract][Full Text] [Related]
8. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Cardiac Arrhythmia Pilot Study (CAPS) Investigators Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169 [TBL] [Abstract][Full Text] [Related]
9. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics. Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186 [TBL] [Abstract][Full Text] [Related]
10. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Bigger JT Am J Cardiol; 1990 Feb; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253 [TBL] [Abstract][Full Text] [Related]
11. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias. Anderson JL Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254 [TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias. Bongiorni MG; Levorato D; Arlotta C; Paperini L; Contini C Eur Heart J; 1988 Jul; 9(7):765-76. PubMed ID: 3139413 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias. Morganroth J; Oshrain C; Steele PP Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448 [TBL] [Abstract][Full Text] [Related]
14. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms. Horowitz LN Am J Cardiol; 1986 Aug; 58(5):83C-86C. PubMed ID: 3092624 [TBL] [Abstract][Full Text] [Related]